RACECADOTRIL is used to treat symptoms of acute (short-term) diarrhoea in adults and infants greater than 3 months of age. RACECADOTRIL can be administered as a complementary treatment when acute diarrhoea cannot be treated casually. Acute diarrhoea occurs when there is a sudden onset of 3 or more loose/watery stools per day for at least 14 days.

RACECADOTRIL contains ‘Racecadotril’, which is a prodrug (inactive form) that gets converted into ‘thiorphan’ (active form), which acts on the epithelium tissues of the small intestine. It helps in decreasing the intestinal hypersecretion (losing) of electrolytes and water induced by the cholera toxin or inflammation. Thus, RACECADOTRIL exerts rapid antidiarrheal action, without changing the duration of intestinal transit (bowel transit time or time of food travel in the digestive tract).